Free Trial

Kooth (KOO) Competitors

Kooth logo
GBX 162 -7.00 (-4.14%)
(As of 11/15/2024 ET)

KOO vs. INS, RENX, COG, INHC, FDBK, IQAI, DVRG, TRLS, SENS, and EMIS

Should you be buying Kooth stock or one of its competitors? The main competitors of Kooth include Instem (INS), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), and EMIS Group (EMIS). These companies are all part of the "health information services" industry.

Kooth vs.

Kooth (LON:KOO) and Instem (LON:INS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, community ranking, analyst recommendations, dividends, institutional ownership and media sentiment.

Kooth currently has a consensus price target of GBX 585, indicating a potential upside of 261.11%. Given Kooth's stronger consensus rating and higher probable upside, equities analysts clearly believe Kooth is more favorable than Instem.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kooth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Instem
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Instem received 83 more outperform votes than Kooth when rated by MarketBeat users. However, 90.91% of users gave Kooth an outperform vote while only 52.25% of users gave Instem an outperform vote.

CompanyUnderperformOutperform
KoothOutperform Votes
10
90.91%
Underperform Votes
1
9.09%
InstemOutperform Votes
93
52.25%
Underperform Votes
85
47.75%

Kooth has higher earnings, but lower revenue than Instem. Kooth is trading at a lower price-to-earnings ratio than Instem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kooth£54.17M1.09£4.28M£0.121,350.00
Instem£61.63M3.24£3.34M£0.145,928.57

Kooth has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500. Comparatively, Instem has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500.

Kooth has a net margin of 7.89% compared to Instem's net margin of 5.50%. Kooth's return on equity of 23.83% beat Instem's return on equity.

Company Net Margins Return on Equity Return on Assets
Kooth7.89% 23.83% 10.12%
Instem 5.50%6.35%4.62%

65.0% of Kooth shares are held by institutional investors. Comparatively, 65.9% of Instem shares are held by institutional investors. 17.3% of Kooth shares are held by insiders. Comparatively, 30.0% of Instem shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Kooth's average media sentiment score of 0.00 equaled Instem'saverage media sentiment score.

Company Overall Sentiment
Kooth Neutral
Instem Neutral

Summary

Kooth beats Instem on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KOO vs. The Competition

MetricKoothHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£59.10M£160.58M£5.16B£1.65B
Dividend YieldN/A6.94%5.18%6.87%
P/E Ratio1,350.00599.4068.561,784.26
Price / Sales1.09286.531,271.87253,178.35
Price / Cash5.4242.4339.7127.62
Price / Book2.354.326.482.85
Net Income£4.28M-£7.04M£119.82M£159.30M
7 Day Performance-4.71%0.04%-5.13%-0.63%
1 Month Performance-42.37%2.59%-2.71%3.41%
1 Year Performance-45.64%-0.48%31.10%126.74%

Kooth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KOO
Kooth
N/AGBX 162
-4.1%
GBX 585
+261.1%
-46.0%£59.10M£54.17M1,350.00478
INS
Instem
N/AN/AN/A+0.0%£199.62M£61.63M5,928.57500
RENX
Renalytix
N/AGBX 7.50
-6.3%
N/A-68.6%£12.45M£2.29M-31.25102
COG
Cambridge Cognition
N/AGBX 29
+1.8%
N/A-48.2%£12.16M£13.08M-725.0080Gap Down
INHC
Induction Healthcare Group
N/AGBX 8.95
-8.2%
N/A-63.4%£8.40M£13.65M-298.3374Gap Down
High Trading Volume
FDBK
Feedback
N/AGBX 20.35
-0.7%
N/A-74.4%£2.71M£1.18M-81.4024High Trading Volume
IQAI
IQ-AI
N/AGBX 1.02
-7.7%
N/A-72.5%£2.25M£538,190.00-13.676
DVRG
DeepVerge
N/AGBX 0.15
flat
N/AN/A£1.14M£12.41M-15.0073
TRLS
Trellus Health
N/AGBX 0.65
-3.7%
N/A-85.8%£1.05M£35,000.00-21.6731Gap Down
SENS
Sensyne Health
N/AGBX 0.35
-33.3%
N/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AGBX 1,920
flat
N/AN/A£1.23B£176.86M4,085.111,560

Related Companies and Tools


This page (LON:KOO) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners